Cooper Companies (NASDAQ:COO) Price Target Cut to $73.00 by Analysts at Needham & Company LLC

Cooper Companies (NASDAQ:COO) had its price objective dropped by equities researchers at Needham & Company LLC from $86.00 to $73.00 in a report issued on Thursday, MarketBeat.com reports. The brokerage currently has a “buy” rating on the medical device company’s stock. Needham & Company LLC’s price objective suggests a potential upside of 15.00% from the stock’s previous close.

Several other equities research analysts have also recently weighed in on COO. UBS Group started coverage on shares of Cooper Companies in a research report on Tuesday, July 28th. They set a “neutral” rating and a $75.00 price objective for the company. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. The Goldman Sachs Group set a $61.00 price target on Cooper Companies in a report on Wednesday, May 27th. Mizuho set a $85.00 price objective on Cooper Companies and gave the stock an “outperform” rating in a research report on Thursday, June 4th. Finally, Wells Fargo & Company restated a “sell” rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $75.27.

Cooper Companies Price Performance

Shares of COO opened at $63.48 on Thursday. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The stock has a market cap of $12.38 billion, a PE ratio of 53.80, a PEG ratio of 1.77 and a beta of 0.82. Cooper Companies has a 12-month low of $58.89 and a 12-month high of $89.83. The business has a 50-day simple moving average of $72.42 and a two-hundred day simple moving average of $70.02.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Wednesday, September 9th. The medical device company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.12 by $0.03. The company had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.10 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. Cooper Companies’s revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.49 earnings per share. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. Analysts anticipate that Cooper Companies will post 4.63 earnings per share for the current fiscal year.

Cooper Companies declared that its Board of Directors has authorized a stock buyback plan on Wednesday, September 9th that allows the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization allows the medical device company to buy up to 22.7% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s board believes its shares are undervalued.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the company. California State Teachers Retirement System boosted its holdings in Cooper Companies by 6,101.7% during the second quarter. California State Teachers Retirement System now owns 19,460,014 shares of the medical device company’s stock worth $1,395,478,000 after purchasing an additional 19,146,230 shares during the last quarter. BlackRock Inc. purchased a new stake in Cooper Companies in the 2nd quarter valued at about $1,077,762,000. Generation Investment Management LLP bought a new position in shares of Cooper Companies during the 2nd quarter worth approximately $356,304,000. Wellington Management Group LLP lifted its position in shares of Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after buying an additional 4,756,178 shares in the last quarter. Finally, Jupiter Topco LLC purchased a new position in shares of Cooper Companies in the 2nd quarter worth approximately $305,074,000. 24.39% of the stock is owned by institutional investors.

Trending Headlines about Cooper Companies

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: CooperCompanies reported fiscal third-quarter adjusted EPS of $1.15, ahead of the $1.11–$1.12 analyst consensus. Revenue reached approximately $1.066 billion, while free cash flow increased 66% to $273 million. CooperCompanies Announces Third Quarter 2026 Results
• Positive Sentiment: The board expanded its share-repurchase authorization from $2 billion to $3 billion, potentially allowing the company to buy back as much as 22.7% of outstanding shares. Management also repurchased $339.1 million of stock during the quarter, supporting per-share value if executed effectively. CooperCompanies Completes Strategic Review
• Neutral Sentiment: GAAP EPS was $2.24, helped substantially by a $307.2 million discrete tax benefit related to the favorable completion of a U.K. tax examination. This benefit improves reported results but is not representative of recurring operating performance. CooperCompanies Reports Third-Quarter Results
• Negative Sentiment: CooperCompanies lowered fiscal 2026 adjusted EPS guidance to $4.51–$4.55, below the roughly $4.63 consensus, and set fourth-quarter EPS guidance at $1.05–$1.09 versus expectations near $1.20. Full-year revenue guidance of $4.229–$4.252 billion also implies modest growth.
• Negative Sentiment: The strategic review concluded that CooperSurgical will be retained because potential offers were not sufficiently attractive. Investors appear disappointed that the company did not unlock value through a sale, particularly amid fertility-related litigation costs and competitive pressure in the IUD market. Reasons Cooper Companies Stock Is Under Pressure

Cooper Companies Company Profile

Cooper Companies, Inc is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company develops, manufactures and markets products through two primary business segments: CooperVision and CooperSurgical.

CooperVision specializes in contact lenses, including daily disposable, toric, multifocal, multifocal toric, specialty and myopia-management lenses. Its products are designed to address a range of vision-correction needs, including astigmatism, presbyopia and irregular corneas.